found that inhibiting TGF‐β can induce mesenchymal‐to‐epithelial transformation (MET) in glioblastoma cells and restore the turnover of TGF‐β‐triggered tight junction proteins, thereby decreasing the mobility of glioblastoma cells. The gene discussed is TGFB1; the disease is glioblastoma.